Alnylam Pharmaceuticals
ALNY
ALNY
226 hedge funds and large institutions have $6.95B invested in Alnylam Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 76 increasing their positions, 64 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
226
Holders Change
+28
Holders Change %
+14.14%
% of All Funds
5.64%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
52
Increased
76
Reduced
64
Closed
22
Calls
$90.2M
Puts
$81.5M
Net Calls
+$8.72M
Net Calls Change
+$6.2M
Top Buyers
Top Sellers
| 1 |
SPC
Slate Path Capital
New York
|
$90.5M |
| 2 |
Franklin Resources
San Mateo,
California
|
$0 |
| 3 |
UBS AM
Chicago,
Illinois
|
$116M |
| 4 |
State Street
Boston,
Massachusetts
|
$155M |
| 5 |
Dodge & Cox
San Francisco,
California
|
$733M |
